Immunogen reported $103.64M in Current Liabilities for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Current Liabilities Change
Agios Pharmaceuticals AGIO:US USD 53.6M 5.2M
Amgen AMGN:US USD 14.33B 1.71B
Astellas Pharma 4503:JP JPY 761.41B 20.87B
AstraZeneca AZN:LN USD 24.85B 3.04B
Bluebird Bio BLUE:US USD 126.73M 22.13M
Bristol Myers Squibb BMY:US USD 18.93B 1.98B
Eli Lilly And LLY:US USD 15.65B 32.2M
Emergent Biosolutions EBS:US USD 268.4M 8.3M
Exelixis EXEL:US USD 301.73M 2.79M
Halozyme Therapeutics HALO:US USD 109.38M 90.13M
Heron Therapeutics HRTX:US USD 93.88M 15.62M
Immunogen IMGN:US USD 103.64M 16.57M
Intrexon XON:US USD 104.86M 74.96M
Karyopharm Therapeutics KPTI:US USD 61.76M 780K
Macrogenics MGNX:US USD 50.05M 831K
Nektar Therapeutics NKTR:US USD 83.99M 21M
Novartis NVS:US USD 28.16B 514M
Regeneron Pharmaceuticals REGN:US USD 2.88B 154.7M
Seattle Genetics SGEN:US USD 726M 117.48M